Services

Local knowledge and Niche Expertise

Our late Phase Group deploys dedicated specialist project managers and experienced clinical development professionals to deliver services from consultative design and data collection through robust reporting. Our dedicated group focuses on providing specific services designed to support products from the point of approval / marketing authorisation through launch and beyond.

Our expert teams provide Phase IIIb and IV, non-interventional, observational, epidemiology, investigator-initiated trials and registry services. Resbiomed also performs regulatory mandated studies, providing long-term safety surveillance in a real-world setting with dedication and commitment.

We offer a competitive range of services from in depth feasibility through patient recruitment within a highly dedicated Investigative Network to successful study completion.